Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Comparative Effectiveness Research|May 28, 2021
Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor populationSantosh Gautam, Sumesh Kachroo, Richard W DeClue, et al.
Future Oncology (London, England)|January 29, 2021
Real-world patterns on tumor mutation burden testing in a pan-tumor populationSantosh Gautam, Sumesh Kachroo, Richard W DeClue, et al.
Future Oncology (London, England)|May 16, 2023
Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer after start of first-line therapyRichard W DeClue, Maxine D Fisher, Kyna Gooden, et al.
Advances in Therapy|May 20, 2018
An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection FractionDana Drzayich Antol, Adrianne Waldman Casebeer, Richard W DeClue, et al.
Future Oncology (London, England)|May 12, 2023
Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology ClinicsRichard W DeClue, Elizabeth A Szamreta, Santosh Gautam, et al.
Future Oncology (London, England)|October 26, 2021
Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancerWhitney Rhodes, Richard W DeClue, Neil A Accortt, et al.
Cancer Treatment and Research Communications|June 10, 2023
Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or metastatic cervical cancer patients under routine care in the United StatesMugdha Gokhale, Rebekah Yu, Matthew Monberg, et al.
Immunotherapy|August 4, 2021
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancerXinke Zhang, Richard W DeClue, Lisa Herms, et al.
Advances in Therapy|October 12, 2017
Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection FractionNancy M Albert, Dana A Drzayich Antol, Richard W DeClue, et al.
The American Journal of Managed Care|June 18, 2020
Claims identification of patients with severe cancer-related symptomsRichard W DeClue, Dana Drzayich Antol, Adrianne W Casebeer, et al.
Pageof 2